본문 바로가기
KERD
논문KCI 등재

A Novel Mutation p.L461P in KRT5 Causing Localized Epidermolysis Bullosa Simplex

Jiang Xin|Zhu Yingyu|Sun Huihui|Gu Feng
대한피부과학회 (Korean Dermalogical Association)|2021.02|Annals of Dermatology|제33권 제1호|pp. 11-17|DOI 10.5021/ad.2021.33.1.11

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

MutationEpidermolysis bullosa simplexKeratin 5
주제분류피부과학

초록

Background: Epidermolysis bullosa (EB) is a rare genetic disease with widely different clinical manifestations, but the relationship between genotype and phenotype is not fully understood. In the present study, we recruited a Chinese family in which two members had been diagnosed with localized EB simplex (EBS), with clinical manifestation, including blisters and erosions on the soles of the feet since infancy. Objective: To identify and confirm the genetic variation in a Chinese family diagnosed as localized EBS. Methods: Our study included two patients, other healthy members of the family, and 100 normal controls. Genomic DNA samples were isolated from each participant, and then polymerase chain reaction (PCR) direct sequencing was performed. Results: The results of PCR direct sequencing revealed a novel heterozygous missense mutation in codon 461 of exon 7 of KRT5 (c.1382T＞C), which led to an amino acid change (p.L461P) in the patients with EBS but was absent in unaffected family members and 100 unrelated control samples. Conclusion: The present study broadens the mutational spectrum of EBS, and this knowledge could be harnessed for prenatal screening, gene diagnosis, and gene therapy for localized EBS.

Abstract

Background: Epidermolysis bullosa (EB) is a rare genetic disease with widely different clinical manifestations, but the relationship between genotype and phenotype is not fully understood. In the present study, we recruited a Chinese family in which two members had been diagnosed with localized EB simplex (EBS), with clinical manifestation, including blisters and erosions on the soles of the feet since infancy. Objective: To identify and confirm the genetic variation in a Chinese family diagnosed as localized EBS. Methods: Our study included two patients, other healthy members of the family, and 100 normal controls. Genomic DNA samples were isolated from each participant, and then polymerase chain reaction (PCR) direct sequencing was performed. Results: The results of PCR direct sequencing revealed a novel heterozygous missense mutation in codon 461 of exon 7 of KRT5 (c.1382T＞C), which led to an amino acid change (p.L461P) in the patients with EBS but was absent in unaffected family members and 100 unrelated control samples. Conclusion: The present study broadens the mutational spectrum of EBS, and this knowledge could be harnessed for prenatal screening, gene diagnosis, and gene therapy for localized EBS.

참고문헌 (38)

  1. Uitto J, "Toward treatment and cure of epidermolysis bullosa", Proc Natl Acad Sci U S A, 116, pp.26147~26149 (2019)
  2. Bruckner-Tuderman L, "Newer treatment modalities in epidermolysis bullosa", Indian Dermatol Online J, 10, pp.244~250 (2019)
  3. Lee JYW, "Mutations in KLHL24 add to the molecular heterogeneity of epidermolysis bullosa simplex", J Invest Dermatol, 137, pp.1378~1380 (2017)
  4. Mellado F, "Ophthalmologic approach in epidermolysis bullosa : a crosssectional study with phenotype-genotype correlations", Cornea, 37, pp.442~447 (2018)
  5. Li JG, "A new mutation in the linker 12 domain of keratin 5 in a Chinese family with Weber-Cockayne epidermolysis bullosa simplex", Clin Exp Dermatol, 29, pp.539~541 (2004)
  6. Stawczyk-Macieja M, "A novel de novo mutation p.Ala428Asp in KRT5 gene as a cause of localized epidermolysis bullosa simplex", Exp Dermatol, 28, pp.1131~1134 (2019)
  7. Kowalewski C, "A novel autosomal partially dominant mutation designated G476D in the keratin 5 gene causing epidermolysis bullosa simplex Weber-Cockayne type : a family study with a genetic twist", Int J Mol Med, 20, pp.75~78 (2007)
  8. Flohil SC, "A new pathogenic keratin 5 mutation in a Hindoestan family with localized epidermolysis bullosa simplex", Eur J Dermatol, 20, pp.27~79 (2010)
  9. Khani P, "Keratins and epidermolysis bullosa simplex", J Cell Physiol, 234, pp.289~297 (2018)
  10. Arin MJ, "Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex : correlation between genotype and phenotype", Br J Dermatol, 162, pp.1365~1369 (2010)
  11. Humphries MM, "Three keratin gene mutations account for the majority of dominant simplex epidermolysis bullosa cases within the population of Ireland", Hum Mutat, 8, pp.57~63 (1996)
  12. Fine JD, "Inherited epidermolysis bullosa : updated recommendations on diagnosis and classification", J Am Acad Dermatol, 70, pp.1103~1126 (2014)
  13. Wertheim-Tysarowska K, "Novel sporadic and recurrent mutations in KRT5 and KRT14 genes in Polish epidermolysis bullosa simplex patients : further insights into epidemiology and genotype-phenotype correlation", J Appl Genet, 57, pp.175~181 (2016)
  14. Kim EN, "A review of 52 pedigrees with epidermolysis bullosa simplex identifying ten novel mutations in KRT5 and KRT14 in Australia", Acta Derm Venereol, 97, pp.1114~1119 (2017)
  15. Jerábková B, "Keratin mutations in patients with epidermolysis bullosa simplex : correlations between phenotype severity and disturbance of intermediate filament molecular structure", Br J Dermatol, 162, pp.1004~1013 (2010)
  16. Kim E, "Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14", Br J Dermatol, 177, pp.262~264 (2017)
  17. Minakawa S, "Mutational analysis on 16 Japanese population cases with epidermolysis bullosa simplex", J Dermatol Sci, 72, pp.330~332 (2013)
  18. Glász-Bóna A, "Easy method for keratin 14 gene amplification to exclude pseudogene sequences : new keratin 5and 14 mutations in epidermolysis bullosa simplex", J Invest Dermatol, 129, pp.229~231 (2009)
  19. García M, "Two novel recessive mutations in KRT14identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex", Br J Dermatol, 165, pp.683~692 (2011)
  20. Bowden PE, "A novel mutation (p.Thr198Ser) in the 1A helix of keratin 5 causes the localized variant of epidermolysis bullosa simplex", Exp Dermatol, 18, pp.650~652 (2009)
  21. Gao J, "Novel keratin 5mutation in a family with epidermolysis bullosa simplex", Exp Ther Med, 10, pp.2432~2436 (2015)
  22. 조재위, "Weber-Cockayne Type Epidermolysis Bullosa Simplex Resulting from a Novel Mutation (c. 608T>C) in the Keratin 5 Gene", Annals of Dermatology, 26(6), pp.739~742 (2014), 대한피부과학회
  23. Chiang YY, "WeberCockayne type of epidermolysis bullosa simplex associated with a novel mutation in keratin 5 and amyloid deposits", Br J Dermatol, 159, pp.1370~1372 (2008)
  24. Lev-Tov H, "A novel keratin 5mutation in a familial cluster", Dermatol Online J, 18, pp.1~ (2012)
  25. Bchetnia M, "Expression signature of epidermolysis bullosa simplex", Hum Genet, 131, pp.393~406 (2012)
  26. Steinert PM, "The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer", J Biol Chem, 265, pp.8766~8774 (1990)
  27. Peking P, "An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex", Br J Dermatol, 180, pp.141~148 (2019)
  28. Bohnekamp J, "A drosophila model of epidermolysis bullosa simplex", J Invest Dermatol, 135, pp.2031~2039 (2015)
  29. Sawant M, "Threonine 150 phosphorylation of keratin 5is linked to epidermolysis bullosa simplex and regulates filament assembly and cell viability", J Invest Dermatol, 138, pp.627~636 (2018)
  30. Russell D, "ERK involvement in resistance to apoptosis in keratinocytes with mutant keratin", J Invest Dermatol, 130, pp.671~681 (2010)
  31. Homberg M, "Distinct impact of two keratin mutations causing epidermolysis bullosa simplex on keratinocyte adhesion and stiffness", J Invest Dermatol, 135, pp.2437~2445 (2015)
  32. Swartling C, "Botulinum toxin in the treatment of sweat-worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita", Br J Dermatol, 163, pp.1072~1076 (2010)
  33. Chiaverini C, "Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe", Br J Dermatol, 173, pp.563~564 (2015)
  34. Ablinger M, "Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex", Orphanet J Rare Dis, 13, pp.193~ (2018)
  35. Castela E, "Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment", Br J Dermatol, 180, pp.357~364 (2019)
  36. Mellerio JE, "Potential therapeutic targeting of inflammation in epidermolysis bullosa simplex", Br J Dermatol, 180, pp.258~260 (2019)
  37. Kerns M, "Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and-independent pathways in skin epithelia", Mol Biol Cell, 21, pp.4068~4075 (2010)
  38. Doman JL, "Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors", Nat Biotechnol, 38, pp.620~628 (2020)

이 간행물의 다른 논문 (16건)

Therapeutic New Era for Atopic Dermatitis: Part 1. BiologicsSimpson Eric Lawrence, 최유성, 안지영pp. 1-10PTEN Promoter Hypermethylation Is Associated with Breslow Thickness in Acral Melanoma on the Heel, Forefoot, and Hallux정기양, 조미연, 노미령, 김종훈, 박해석pp. 18-25Keratinocytes-Derived Reactive Oxygen Species Play an Active Role to Induce Type 2 Inflammation of the Skin: A Pathogenic Role of Reactive Oxygen Species at the Early Phase of Atopic Dermatitis이지범, 박준형, 최지영, 이승철, 서민송, 윤숙정, 최다인, Piao MeiShanpp. 26-36Exogenous Local Hyperthermia at 41℃ Is Effective to Eliminate Mouse Model of Sporotrichosis, Independent of Neutrophil Extracellular Traps FormationGao Xing-Hua, Li Zheng-Xiu, Lan Jing, Qi Rui-Qun, Wang Ya-Lanpp. 37-45Alitretinoin Compliance in Patients with Chronic Hand Eczema박소희, 김효진, 김종욱, 박인호, 정소영, 홍성민, 조경제, 진우정, 설정은pp. 46-51
원문 보기